BGF's Early Stage team backs deep tech and life sciences founders across the UK and Ireland with initial investments of £3m–£10m (late seed to Series B), plus access to follow-on funding. Backed by an evergreen fund structure and the resources of a later-stage growth investor with 600+ investments and 200+ exits across the full BGF portfolio.
Deep tech sectors include semiconductors & photonics, advanced materials, AI & software platforms, and energy storage. Life sciences sectors include drug discovery, MedTech, diagnostics, and advanced tools. Must be privately-owned, IP-protected, and HQ'd in the UK or Ireland. Applications accepted on a rolling basis — pitch directly to the Early Stage team.